Accumulation of norepinephrine in rat tissue following treatment with three beta-adrenergic antagonists.
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D004983:Ethanolamines / Q000494:pharmacology*; D005260:Female; D009206:Myocardium / Q000032:analysis / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism*; D011433:Propranolol / Q000494:pharmacology*; D051381:Rats; D013154:Spleen / Q000032:analysis / Q000378:metabolism*; D014665:Vasodilator Agents / Q000494:pharmacology*; D014700:Verapamil / Q000494:pharmacology
D000889:Anti-Arrhythmia Agents; D004983:Ethanolamines; D014665:Vasodilator Agents; D011433:Propranolol; D014700:Verapamil; D009638:Norepinephrine